![Isaac Ciechanover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Isaac Ciechanover
Corporate Officer/Principal bei
CYTOKINETICS, INCORPORATED
Profil
Isaac E.
Ciechanover was the founder of Atara Biotherapeutics, Inc., founded in 2012, where the titles held included Chairman, President & Chief Executive Officer from 2012 to 2019.
Current jobs include Director at Muna Therapeutics ApS; Partner at Polaris Growth Management LLC since 2019; Partner at Qiming US Ventures Management, LLC since 2022; and Chief Business Officer & EVP-Corporate Development at Cytokinetics, Inc. since 2024.
Former jobs include President & Chief Executive Officer at Nina Biotherapeutics, Inc.; President & Chief Executive Officer at Pinta Biotherapeutics, Inc.; President & Chief Executive Officer at Santa Maria Biotherapeutics, Inc.; Chairman at Auron Therapeutics, Inc.; Executive Director-Business Development at Celgene Corp.
from 2004 to 2010; Director at SQZ Biotechnologies Co.; Principal at Amylin Pharmaceuticals, Inc.; and Partner at Kleiner Perkins Caufield & Byers LLC.
Education history includes undergraduate studies at Stanford University, graduate studies at the University of Cambridge, a doctorate from Weill Cornell Medical College, and an MBA from Harvard Business School.
Aktive Positionen von Isaac Ciechanover
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01.06.2024 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Private Equity Investor | 01.06.2022 |
Muna Therapeutics ApS
 Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Direktor/Vorstandsmitglied | - |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Private Equity Investor | 05.12.2019 |
Ehemalige bekannte Positionen von Isaac Ciechanover
| Unternehmen | Position | Ende |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Vorstandsvorsitzender | 28.05.2019 |
| CELGENE | Corporate Officer/Principal | 01.03.2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | - |
Nina Biotherapeutics, Inc.
 Nina Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer patients | Vorstandsvorsitzender | - |
Santa Maria Biotherapeutics, Inc.
 Santa Maria Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Vorstandsvorsitzender | - |
Ausbildung von Isaac Ciechanover
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nina Biotherapeutics, Inc.
Nina Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer patients | Health Technology |
Pinta Biotherapeutics, Inc. | |
Santa Maria Biotherapeutics, Inc.
Santa Maria Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Commercial Services |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
